Agent for improving acidosis

An agent for improving acidosis which comprises an insulin sensitizer.

An agent for preventing or treating hyperosmolar nonketonic coma, infectious disease, diabetic osteoporosis, diabetic gangrene, xerostomia, lowered sense of hearing, angina pectoris, cerebrovascular disease or peripheral circulatory disturbance, which comprises an insulin sensitizer.

An agent for improving ketosis which comprises an insulin sensitizer in combination with insulin.

An agent for improving acidosis which comprises an insulin sensitizer in combination with insulin.

Method for improving or treating ketosis in a mammal in need thereof, which comprises administering to said mammal an effective amount of an insulin sensitizer.

Method for improving or treating acidosis in a mammal in need thereof, which comprises administering to said mammal an effective amount of an insulin sensitizer.

Method for preventing or treating hyperosmolar nonketonic coma, infectious disease, diabetic osteoporosis, diabetic gangrene, xerostomia, lowered sense of hearing, angina pectoris, cerebrovascular disease or peripheral circulatory disturbance in a mammal in need thereof, which comprises administering to said mammal an effective amount of an insulin sensitizer.

Use of an insulin sensitizer for the manufacture of a pharmaceutical preparation for improving or treating ketosis.

Use of an insulin sensitizer for the manufacture of a pharmaceutical preparation for improving or treating acidosis.

Use of an insulin sensitizer for the manufacture of a pharmaceutical preparation for treating hyperosmolar nonketonic coma, infectious disease, diabetic osteoporosis, diabetic gangrene, xerostomia, lowered sense of hearing, angina pectoris, cerebrovascular disease or peripheral circulatory disturbance.